Skip to main content

UNC Neurology Receives New Center of Excellence Designation

September 1, 2021

The Division of Neuromuscular Disorders has been designated as a GBS|CIDP Foundation International Center of Excellence for the diagnosis and treatment of Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and other inflammatory peripheral neuropathies.

Aducanumab Update

July 15, 2021

Learn about aducanumab and UNC Neurology’s position on the new drug approved by the FDA for Alzheimer’s disease.

Almodóvar-Suárez Named Director of ALS Clinic

June 25, 2021

Jorge L. Almodóvar-Suárez, MD, associate professor of general neurology and neuromuscular disorders, is the new director of the UNC Department of Neurology’s Amyotrophic Lateral Sclerosis (ALS) Clinic. Born and raised in Puerto Rico, Dr. Almodóvar-Suárez is graduate of the state-funded University of Puerto Rico System, and a faithful believer of education and health care for … Continued

RFA: Alzheimer’s Disease Research – Norins Pilot Awards

June 9, 2021

The Duke/UNC Alzheimer’s Disease Research Collaborative is offering $50,000 Norins pilot awards to stimulate and support collaborative, innovative research on the potential role of microbes or pathogens in the development of Alzheimer’s disease. The principal investigator must be a Duke University faculty member or postdoctoral fellow, but cross-disciplinary and cross-institutional collaborations is strongly encouraged.